FDA approves new streamlined workflow option for Roche's cobas HPV Test
June 26, 2013 at 11:00 AM EDT
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, more efficient workflow process for the cobas HPV Test, allowing sample processing from the primary sample collection vial after it has been used for cytology (Pap) testing. This development allows